JP2006520343A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006520343A5 JP2006520343A5 JP2006504553A JP2006504553A JP2006520343A5 JP 2006520343 A5 JP2006520343 A5 JP 2006520343A5 JP 2006504553 A JP2006504553 A JP 2006504553A JP 2006504553 A JP2006504553 A JP 2006504553A JP 2006520343 A5 JP2006520343 A5 JP 2006520343A5
- Authority
- JP
- Japan
- Prior art keywords
- methoxypyridin
- sulfonylamino
- propyl
- butyl
- benzamide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 150000003839 salts Chemical class 0.000 claims 6
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 claims 4
- 239000000654 additive Substances 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 206010003658 Atrial Fibrillation Diseases 0.000 claims 1
- 206010003662 Atrial flutter Diseases 0.000 claims 1
- 206010042600 Supraventricular arrhythmias Diseases 0.000 claims 1
- -1 [1 (R)-(6-methoxypyridin-3-yl) propyl] benzamide Chemical compound 0.000 claims 1
- 206010003119 arrhythmia Diseases 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
Claims (8)
- 請求項1に記載の2−(ブチル−1−スルホニルアミノ)−N−[1(R)−(6−メトキシピリジン−3−イル)プロピル]ベンズアミド。
- 医薬品として使用するための請求項1又は2に記載の2−(ブチル−1−スルホニルアミノ)−N−[1(R)−(6−メトキシピリジン−3−イル)プロピル]ベンズアミド又はその生理学上受容できる塩。
- 心臓性不整脈、上室性不整脈、心房性細動又は心房性粗動の治療又は予防のための医薬品の製造における請求項1又は2に記載の2−(ブチル−1−スルホニルアミノ)−N−[1(R)−(6−メトキシピリジン−3−イル)プロピル]ベンズアミド又はその生理学上受容できる塩の使用。
- 請求項1又は2に記載の2−(ブチル−1−スルホニルアミノ)−N−[1(R)−(6−メトキシピリジン−3−イル)プロピル]ベンズアミド又はその生理学上受容できる塩の有効量を、製薬的に受容可能なビヒクル及び添加物と共に含有するヒトの又は獣医学的使用のための医薬製剤。
- 請求項1又は2に記載の2−(ブチル−1−スルホニルアミノ)−N−[1(R)−(6−メトキシピリジン−3−イル)プロピル]ベンズアミド又はその生理学上受容できる塩の有効量と、製薬的に受容可能なビヒクル及び添加物、並びに、場合によっては、さらに1又はそれ以上の薬理学的活性化合物を共に含有するヒトの又は獣医学的使用のための医薬製剤。
- 1(R)−(6−メトキシピリジン−3−イル)プロピルアミン。
- 2−(ブチル−1−スルホニルアミノ)−N−[1(R)−(6−メトキシピリジン−3−イル)プロピル]ベンズアミド又はその生理学上受容できる塩の製造のための中間体としての1(R)−(6−メトキシピリジン−3−イル)プロピルアミンの使用。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10312073A DE10312073A1 (de) | 2003-03-18 | 2003-03-18 | 2-(Butyl-1-sulfonylamino)-N-[1(R)-(6-methoxy-pyridin-3yl)-propyl]-benzamid, dessen Verwendung als Medikament sowie dieses enthaltende pharmazeutische Zubereitungen |
PCT/EP2004/002247 WO2004083157A1 (de) | 2003-03-18 | 2004-03-05 | 2-(butyl-1-sulfonylamino)-n-[1(r)-(6-methoxy-pyridin-3-yl)-propyl]-benzamid, dessen verwendung als medikament sowie dieses enthaltende pharmazeutische zubereitungen |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2006520343A JP2006520343A (ja) | 2006-09-07 |
JP2006520343A5 true JP2006520343A5 (ja) | 2007-04-19 |
Family
ID=32920928
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006504553A Abandoned JP2006520343A (ja) | 2003-03-18 | 2004-03-05 | 2−(ブチル−1−スルホニルアミノ)−n−[1(r)−(6−メトキシピリジン−3−イル)プロピル]ベンズアミド、医薬としてのその使用及び該化合物を含有する医薬製剤 |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP1606237A1 (ja) |
JP (1) | JP2006520343A (ja) |
KR (1) | KR20050110681A (ja) |
CN (1) | CN100361943C (ja) |
AR (1) | AR043622A1 (ja) |
AU (1) | AU2004222137A1 (ja) |
BR (1) | BRPI0408441A (ja) |
CA (1) | CA2519022A1 (ja) |
DE (1) | DE10312073A1 (ja) |
HK (1) | HK1086819A1 (ja) |
HR (1) | HRP20050815A2 (ja) |
MA (1) | MA27749A1 (ja) |
MX (1) | MXPA05009763A (ja) |
MY (1) | MY176510A (ja) |
NO (1) | NO20054472L (ja) |
NZ (1) | NZ542476A (ja) |
PE (1) | PE20050307A1 (ja) |
RS (1) | RS20050690A (ja) |
RU (1) | RU2333202C2 (ja) |
TW (1) | TW200500342A (ja) |
WO (1) | WO2004083157A1 (ja) |
ZA (1) | ZA200506328B (ja) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102004009931A1 (de) * | 2004-02-26 | 2005-09-15 | Aventis Pharma Deutschland Gmbh | Kv1.5-Blocker zur selektiven Steigerung der Vorhofkontraktilität und Behandlung der Herzinsuffizienz |
US7569589B2 (en) | 2004-07-29 | 2009-08-04 | Merck & Co., Inc. | Potassium channel inhibitors |
DE102005028845A1 (de) * | 2005-06-22 | 2006-12-28 | Sanofi-Aventis Deutschland Gmbh | Substituierte Heterocyclen, ihre Verwendung als Medikament sowie enthaltende pharmazeutische Zubereitungen |
JP4943429B2 (ja) * | 2005-07-22 | 2012-05-30 | メルク・シャープ・エンド・ドーム・コーポレイション | カリウムチャネル阻害剤 |
US9101616B2 (en) | 2009-05-29 | 2015-08-11 | Raqualia Pharma Inc. | Aryl substituted carboxamide derivatives as calcium or sodium channel blockers |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10121003A1 (de) * | 2001-04-28 | 2002-12-19 | Aventis Pharma Gmbh | Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
-
2003
- 2003-03-18 DE DE10312073A patent/DE10312073A1/de not_active Withdrawn
-
2004
- 2004-03-05 EP EP04717628A patent/EP1606237A1/de not_active Withdrawn
- 2004-03-05 RS YUP-2005/0690A patent/RS20050690A/sr unknown
- 2004-03-05 PE PE2004000245A patent/PE20050307A1/es not_active Application Discontinuation
- 2004-03-05 KR KR1020057017498A patent/KR20050110681A/ko not_active Application Discontinuation
- 2004-03-05 BR BRPI0408441-1A patent/BRPI0408441A/pt not_active IP Right Cessation
- 2004-03-05 RU RU2005132163/04A patent/RU2333202C2/ru not_active IP Right Cessation
- 2004-03-05 WO PCT/EP2004/002247 patent/WO2004083157A1/de active Application Filing
- 2004-03-05 JP JP2006504553A patent/JP2006520343A/ja not_active Abandoned
- 2004-03-05 NZ NZ542476A patent/NZ542476A/en unknown
- 2004-03-05 CN CNB2004800060168A patent/CN100361943C/zh not_active Expired - Fee Related
- 2004-03-05 CA CA002519022A patent/CA2519022A1/en not_active Abandoned
- 2004-03-05 MX MXPA05009763A patent/MXPA05009763A/es active IP Right Grant
- 2004-03-05 AU AU2004222137A patent/AU2004222137A1/en not_active Abandoned
- 2004-03-16 TW TW093106899A patent/TW200500342A/zh unknown
- 2004-03-16 AR ARP040100866A patent/AR043622A1/es unknown
- 2004-03-17 MY MYPI20040938A patent/MY176510A/en unknown
-
2005
- 2005-08-08 ZA ZA200506328A patent/ZA200506328B/en unknown
- 2005-09-16 HR HR20050815A patent/HRP20050815A2/xx not_active Application Discontinuation
- 2005-09-19 MA MA28502A patent/MA27749A1/fr unknown
- 2005-09-27 NO NO20054472A patent/NO20054472L/no not_active Application Discontinuation
-
2006
- 2006-06-16 HK HK06106891A patent/HK1086819A1/xx not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2021063088A5 (ja) | ||
JP2008513510A5 (ja) | ||
JP2004512328A5 (ja) | ||
JP2009280627A5 (ja) | ||
JP2008526757A5 (ja) | ||
JP2009544665A5 (ja) | ||
JP2005508955A5 (ja) | ||
JP2013500977A5 (ja) | ||
JP2008508350A5 (ja) | ||
JP2005508337A5 (ja) | ||
RU2004135563A (ru) | Лекарственное средство для лечения повышенной активности мочевого пузыря | |
JP2002528502A5 (ja) | ||
JP2005513014A5 (ja) | ||
JP2019533660A5 (ja) | ||
JP2006520343A5 (ja) | ||
RU2005133665A (ru) | Применение производных 10-гидрокси-10,11-дигидрокарбамазепина для лечения аффективных расстройств | |
RU99121654A (ru) | Средства для предотвращения или лечения болезней, связанных с чрезмерной пролиферацией эпителиальных пигментных клеток сетчатки | |
JP2008543813A5 (ja) | ||
JP2002537232A5 (ja) | ||
JP2011520877A5 (ja) | ||
Strohmer et al. | Atrial fibrillation and prominent J (Osborn) waves in critical hypothermia | |
JP2004525912A5 (ja) | ||
JP2008522955A5 (ja) | ||
RU2005132163A (ru) | 2-(бутил-1-сульфониламино)-n-[1(r)-(6-метоксипиридин-3-ил)-пропил]бензамид, его применение в качестве лекарственного средства, а также содержащие его фармацевтические композиции | |
WO2005011602A3 (en) | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a pde-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease |